Science and Research

Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1"

  • Petzold, T.
  • Thienel, M.
  • Dannenberg, L.
  • Mourikis, P.
  • Helten, C.
  • Ayhan, A.
  • M'Pembele, R.
  • Achilles, A.
  • Trojovky, K.
  • Zhang, Z.
  • Regenauer, R.
  • Pircher, J.
  • Ehrlich, A.
  • Lüsebrink, E.
  • Nicolai, L.
  • Stocker, T. J.
  • Brandl, R.
  • Röschenthaler, F.
  • Strecker, J.
  • Saleh, I.
  • Spannagl, M.
  • Mayr, C. H.
  • Schiller, H. B.
  • Jung, C.
  • Gerdes, N.
  • Hoffmann, T.
  • Levkau, B.
  • Hohlfeld, T.
  • Zeus, T.
  • Schulz, C.
  • Kelm, M.
  • Polzin, A.

Keywords

  • Humans
  • Peptide Hydrolases
  • Platelet Activation
  • Receptor, PAR-1
  • *Rivaroxaban
  • *Thrombosis/drug therapy/prevention & control
Publication details
DOI: 10.1161/circresaha.120.316786
Journal: Circ Res
Pages: e54-e55 
Number: 8
Work Type: Original
Location: CPC-M
Disease Area: General Lung and Other
Partner / Member: HMGU
Access-Number: 32271680

DZL Engagements

chevron-down